Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication.

Vickers A, Cronin A, Roobol M, Savage C, Peltola M, Pettersson K, Scardino PT, Schröder F, Lilja H.

J Clin Oncol. 2010 May 20;28(15):2493-8. doi: 10.1200/JCO.2009.24.1968. Epub 2010 Apr 26.

PMID:
20421547
2.

Effect of dutasteride on the risk of prostate cancer.

Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS; REDUCE Study Group.

N Engl J Med. 2010 Apr 1;362(13):1192-202. doi: 10.1056/NEJMoa0908127.

PMID:
20357281
3.

Prostate cancer early detection. Clinical practice guidelines in oncology.

National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2004 May;2(3):190-207.

PMID:
19795604
4.

Prostate specific antigen best practice statement: 2009 update.

Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P.

J Urol. 2009 Nov;182(5):2232-41. doi: 10.1016/j.juro.2009.07.093. Epub 2009 Sep 24.

PMID:
19781717
5.

Prostate specific antigen for early detection of prostate cancer: longitudinal study.

Holmström B, Johansson M, Bergh A, Stenman UH, Hallmans G, Stattin P.

BMJ. 2009 Sep 24;339:b3537. doi: 10.1136/bmj.b3537.

PMID:
19778969
6.

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.

Welch HG, Albertsen PC.

J Natl Cancer Inst. 2009 Oct 7;101(19):1325-9. doi: 10.1093/jnci/djp278. Epub 2009 Aug 31.

PMID:
19720969
7.

Prostate-cancer screening.

Catalona WJ.

N Engl J Med. 2009 Jul 9;361(2):202; author reply 204-5. doi: 10.1056/NEJMc090849. No abstract available.

PMID:
19587348
8.

Screening and prostate-cancer mortality in a randomized European study.

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators.

N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.

PMID:
19297566
9.

Mortality results from a randomized prostate-cancer screening trial.

Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD; PLCO Project Team.

N Engl J Med. 2009 Mar 26;360(13):1310-9. doi: 10.1056/NEJMoa0810696. Epub 2009 Mar 18. Erratum in: N Engl J Med. 2009 Apr 23;360(17):1797.

PMID:
19297565
10.

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.

Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, Feuer E, de Koning H.

J Natl Cancer Inst. 2009 Mar 18;101(6):374-83. doi: 10.1093/jnci/djp001. Epub 2009 Mar 10.

PMID:
19276453
11.

Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.

Kramer BS, Hagerty KL, Justman S, Somerfield MR, Albertsen PC, Blot WJ, Ballentine Carter H, Costantino JP, Epstein JI, Godley PA, Harris RP, Wilt TJ, Wittes J, Zon R, Schellhammer P; American Society of Clinical Oncology Health Services Committee; American Urological Association Practice Guidelines Committee.

J Clin Oncol. 2009 Mar 20;27(9):1502-16. doi: 10.1200/JCO.2008.16.9599. Epub 2009 Feb 24. Review. Erratum in: J Clin Oncol. 2009 Jun 1;27(16):2742.

PMID:
19252137
12.

Clinical risk factors, DNA variants, and the development of type 2 diabetes.

Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T, Berglund G, Altshuler D, Nilsson P, Groop L.

N Engl J Med. 2008 Nov 20;359(21):2220-32. doi: 10.1056/NEJMoa0801869.

PMID:
19020324
13.

Statistical methods to correct for verification bias in diagnostic studies are inadequate when there are few false negatives: a simulation study.

Cronin AM, Vickers AJ.

BMC Med Res Methodol. 2008 Nov 11;8:75. doi: 10.1186/1471-2288-8-75.

PMID:
19014457
14.

The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review.

Schröder F, Kattan MW.

Eur Urol. 2008 Aug;54(2):274-90. doi: 10.1016/j.eururo.2008.05.022. Epub 2008 May 22. Review.

PMID:
18511177
15.

Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.

Ross LE, Berkowitz Z, Ekwueme DU.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):636-44. doi: 10.1158/1055-9965.EPI-07-2709.

PMID:
18349281
16.

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.

Ulmert D, Cronin AM, Björk T, O'Brien MF, Scardino PT, Eastham JA, Becker C, Berglund G, Vickers AJ, Lilja H.

BMC Med. 2008 Feb 15;6:6. doi: 10.1186/1741-7015-6-6.

PMID:
18279502
17.

Estimating the empirical Lorenz curve and Gini coefficient in the presence of error with nested data.

Moskowitz CS, Seshan VE, Riedel ER, Begg CB.

Stat Med. 2008 Jul 20;27(16):3191-208. doi: 10.1002/sim.3151.

PMID:
18172873
18.

Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.

Adolfsson J, Garmo H, Varenhorst E, Ahlgren G, Ahlstrand C, Andrén O, Bill-Axelson A, Bratt O, Damber JE, Hellström K, Hellström M, Holmberg E, Holmberg L, Hugosson J, Johansson JE, Petterson B, Törnblom M, Widmark A, Stattin P.

Scand J Urol Nephrol. 2007;41(6):456-77.

PMID:
17934985
19.

Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence.

Haas GP, Delongchamps NB, Jones RF, Chandan V, Serio AM, Vickers AJ, Jumbelic M, Threatte G, Korets R, Lilja H, de la Roza G.

J Natl Cancer Inst. 2007 Oct 3;99(19):1484-9. Epub 2007 Sep 25.

PMID:
17895474
20.

Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04.

Lacher DA, Thompson TD, Hughes JP, Saraiya M.

Adv Data. 2006 Dec 4;(379):1-12.

PMID:
17348177

Supplemental Content

Support Center